Kusajili – Clinical trials directory

Result of your search per sponsor: Harry Janssen, Prof. dr

Woman and Man Max 99 years
Harry Janssen, Prof. dr Update Il y a 4 ans

Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B The purpose of this study is to investigate whether it is possible to augment the response of patients with HBeAg-positive chronic hepatitis B to entecavir by using a temporary peginterfer...

Country China, Netherlands, Poland, Romania, Turkey
organs None
Specialty None

Closed trial

More information